FRASCA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 5.696
EU - Europa 3.051
AS - Asia 2.866
SA - Sud America 456
AF - Africa 413
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 12.495
Nazione #
US - Stati Uniti d'America 5.480
SG - Singapore 1.485
CN - Cina 909
IT - Italia 907
RU - Federazione Russa 845
IE - Irlanda 450
BR - Brasile 398
UA - Ucraina 372
CI - Costa d'Avorio 313
CA - Canada 177
DE - Germania 169
VN - Vietnam 128
KR - Corea 106
IN - India 69
GB - Regno Unito 59
SE - Svezia 55
SN - Senegal 47
PL - Polonia 29
FR - Francia 28
FI - Finlandia 27
MX - Messico 26
TR - Turchia 26
AR - Argentina 25
IR - Iran 24
NL - Olanda 22
CH - Svizzera 20
JP - Giappone 19
UZ - Uzbekistan 17
CZ - Repubblica Ceca 15
ZA - Sudafrica 15
BD - Bangladesh 14
BJ - Benin 14
ES - Italia 14
ID - Indonesia 14
EC - Ecuador 12
BE - Belgio 9
GR - Grecia 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
AZ - Azerbaigian 6
CO - Colombia 6
PY - Paraguay 6
SA - Arabia Saudita 6
EU - Europa 5
KE - Kenya 5
MA - Marocco 5
VE - Venezuela 5
BG - Bulgaria 4
HK - Hong Kong 4
LT - Lituania 4
NG - Nigeria 4
PK - Pakistan 4
RO - Romania 4
AT - Austria 3
DO - Repubblica Dominicana 3
IL - Israele 3
LB - Libano 3
LU - Lussemburgo 3
TN - Tunisia 3
BH - Bahrain 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
PS - Palestinian Territory 2
TW - Taiwan 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
BN - Brunei Darussalam 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.495
Città #
Dallas 886
Singapore 859
Santa Clara 735
Chandler 491
Dublin 449
Chicago 404
Moscow 397
Jacksonville 391
Abidjan 313
Houston 245
Ashburn 237
Hefei 219
Boardman 203
Catania 197
Civitanova Marche 164
Los Angeles 143
Beijing 130
Quintano 129
Nanjing 127
Cambridge 122
Lawrence 121
Andover 119
Toronto 115
Seoul 105
Grafing 79
Wilmington 71
San Mateo 62
Des Moines 59
Buffalo 49
Dakar 47
Ho Chi Minh City 46
Nanchang 44
New York 43
Bremen 39
São Paulo 39
Palermo 35
Hebei 34
Jiaxing 31
Munich 30
Saint Petersburg 29
Shenyang 29
Ottawa 28
Council Bluffs 27
The Dalles 27
Bari 26
Hanoi 26
Columbus 25
Kochi 24
Changsha 23
Tianjin 22
Warsaw 22
San Francisco 20
Tokyo 19
Milan 17
Ardabil 16
Atlanta 16
Lappeenranta 16
Montreal 16
Stockholm 16
Amsterdam 15
Brooklyn 15
Rio de Janeiro 15
Cotonou 14
Brno 13
Manchester 13
Orem 12
Pozzallo 12
Rome 12
Augusta 11
Denver 11
Dong Ket 11
Phoenix 11
Pune 11
Washington 11
Chennai 10
Johannesburg 10
Mascalucia 10
Redondo Beach 10
Seattle 10
Ankara 9
Brussels 9
Curitiba 9
Leawood 9
Paternò 9
San Jose 9
Belpasso 8
Brasília 8
Jinan 8
London 8
Mexico City 8
Vancouver 8
Campinas 7
Falls Church 7
Guangzhou 7
Mumbai 7
Redwood City 7
Turku 7
Belo Horizonte 6
Jakarta 6
Naples 6
Totale 8.852
Nome #
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells 338
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 181
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 179
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells 168
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 158
c-Abl and insulin receptor signalling 157
Different FT3/TSH correlation in acquired and congenital hypothyroid patients reveals a different hypothalamic set-point 139
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 135
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 135
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 135
BRAF(V600E) mutation and the biology of papillary thyroid cancer 129
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 129
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 127
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 126
Curcumin, hormesis and the nervous system 125
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 123
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 122
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells 122
Challenges in the treatment of parathyroid carcinoma: a case report 122
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 116
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves' Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 115
Early detection of suspicious lymph nodes in differentiated thyroid cancer 115
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study 114
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 112
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 112
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 110
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 109
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 107
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 107
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 106
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 105
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 104
Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway 102
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 100
Insulin receptor isoforms in physiology and disease: An updated view 100
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend 99
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids 98
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 97
Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer 96
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 93
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 93
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 90
Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis 90
p73 tumor-suppressor activity is impaired in human thyroid cancer 90
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 90
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review 88
p53 family proteins in thyroid cancer 87
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 87
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 86
Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence 85
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 85
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 85
Cytological diagnosis difficulties in hyalinizing trabecular adenoma of the thyroid 84
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 84
Papillary thyroid cancer incidence in the volcanic area of Sicily 84
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 84
The p53-homologue p63 may promote thyroid cancer progression 83
Isolation and characteriziation of cancer thyrospheres 83
The isoform A of the insulin receptor as a regulator of the IGF system 82
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 82
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 81
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 81
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 81
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 81
Clinical Assessment of Altered Eating Behaviors in People with Obesity Using the EBA-O Questionnaire 81
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 80
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 80
Thyroid Cancer and Circadian Clock Disruption 80
Endocrinopatie e anemie / anemie ed endocrinopatie: una si(pali)ndrome spesso misconosciuta 79
Seasonal Variations in TSH Serum Levels in Athyreotic Patients under L-Thyroxine Replacement Monotherapy. 79
Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts 79
Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem 78
Nuove strategie di indagine delle linfoadenopatie nel carcinoma tiroideo 78
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 78
Associazione tra la sindrome metabolica e le caratteristiche clinico-patologiche del carcinoma papillifero tiroideo 78
The SGLT-1/SGLT-2 dual inhibitor canagliflozin has positive effects on glucose trends, targets and variability in late dumping syndrome following gastrectomy: A case report 76
Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review 76
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 76
Le cellule staminali tiroidee, isolate da gozzi di soggetti adulti, crescono in aggregati sferici in risposta a stimolazione con fattori di crescita e necessitano del TSH per differenziare in Tireociti maturi 76
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 76
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 76
The role of insulin receptor isoform a (IR-A) in cancer 76
Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity 75
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 75
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 75
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells 74
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 74
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 74
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years 74
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 73
Obesity, insulin-resistance and cancer 73
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement 73
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription 72
Thyrospheres an in vitro model for human thyroid carcinogenesis 72
The Insulin Receptor in Breast Cancer 71
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 71
Sintesi del mechano growth factor (MGF) umano ricombinante nell’Escherichia coli 71
Expression of neurotrophins, GDNF and their receptors in rat thyroid tissue 71
Diabetes and cancer 71
Insulin/IGF-I hybrid receptors are highly expressed in human breast cancer and are activated by IGF-I 70
Totale 9.824
Categoria #
all - tutte 41.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021413 0 0 0 0 0 22 87 14 135 4 127 24
2021/2022879 107 128 6 11 127 9 134 34 81 3 27 212
2022/20231.700 129 46 31 316 150 278 2 264 388 21 46 29
2023/2024829 40 128 33 58 41 153 41 63 6 20 111 135
2024/20253.135 40 615 154 266 629 336 60 93 190 273 237 242
2025/20264.265 403 393 1.130 481 1.019 839 0 0 0 0 0 0
Totale 12.727